BCG Polysaccharide and Nucleic Acid Injection (Shaanxi Medicine Holding Group Biological Products)

卡介菌多糖核酸注射剂(陕西医药控股)

Report date: 2023/11/01 11:28:14

Base Information

Drug NameBCG Polysaccharide and Nucleic Acid Injection (Shaanxi Medicine Holding Group Biological Products)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsTuberculosis, Pulmonary
Approved Indications in ChinaTuberculosis, Pulmonary
Original Approved Country/TerritoryMainland China
Original Approved Date2004/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeL03AX03
Related LinksN/A